GGrantIndex
← Leaderboards

Celine Gelinas

Univ Of Med/Dent Nj-R W Johnson Med Sch

$4,408,045
Attributed
$4,514,417
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $386.2K · FY200525
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,514,417 · 4

By mechanism

R01$3,529,205 · 2
R33$772,468 · 1
R25$212,744 · 1

Top collaborators

Most similar at Univ Of Med/Dent Nj-R W Johnson Med Sch

Same institution · by research overlap

Others in their field

Top investigators on “Nuclear Factor Kappa Beta

Research focus

Nuclear Factor Kappa BetaApoptosisLymphomaResponseSite Directed MutagenesisPathway InteractionsRegulationCell DifferentiationPhosphorylationNeoplasm /Cancer GeneticsMulticatalytic Endopeptidase ComplexBcl2 Gene /ProteinBiological Signal TransductionB LymphocyteOncoproteinsCarcinogenesisGenetically Modified AnimalsGenetic TranscriptionLaboratory MouseChickensAffectCellsGene Induction /RepressionInsight

Grant awards (19)

5/6 NJ ACTS: A Platform for Translational Science in New Jersey: CTSA R25 at Rutgers, Biomedical Health Sciences$106,372
R25 · FY2025 · TR · contact PI
5/6 NJ ACTS: A Platform for Translational Science in New Jersey: CTSA R25 at Rutgers, Biomedical Health Sciences$106,372
R25 · FY2024 · TR · contact PI
Specific activation of latent HIV-1 by inhibiting E3 ubiquitin ligase activity$386,234
R33 · FY2018 · AI · contact PI
Specific activation of latent HIV-1 by inhibiting E3 ubiquitin ligase activity$386,234
R33 · FY2017 · AI · contact PI
Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis$183,634
R01 · FY2011 · CA · contact PI
Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis$58,188
R01 · FY2010 · CA · contact PI
Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis$247,664
R01 · FY2009 · CA · contact PI
Functional analysis of Bfl-1/A1 in apoptosis and oncogenesis$247,822
R01 · FY2008 · CA · contact PI
Trans acting function of the v and c Rel oncoproteins$265,220
R01 · FY2005 · CA
Trans acting function of the v and c Rel oncoproteins$265,383
R01 · FY2004 · CA
THE NF KAPPAB SIGNALING PATHWAY, APOPTOSIS AND CANCER$242,045
R01 · FY2004 · CA
Trans acting function of the v and c Rel oncoproteins$265,542
R01 · FY2003 · CA
THE NF KAPPAB SIGNALING PATHWAY, APOPTOSIS AND CANCER$242,045
R01 · FY2003 · CA
Trans acting function of the v and c Rel oncoproteins$265,696
R01 · FY2002 · CA
THE NF KAPPAB SIGNALING PATHWAY, APOPTOSIS AND CANCER$242,045
R01 · FY2002 · CA
Trans acting function of the v and c Rel oncoproteins$265,845
R01 · FY2001 · CA
THE NF KAPPAB SIGNALING PATHWAY, APOPTOSIS AND CANCER$242,045
R01 · FY2001 · CA
THE NF KAPPAB SIGNALING PATHWAY, APOPTOSIS AND CANCER$264,545
R01 · FY2000 · CA
TRANS-ACTING FUNCTION OF THE V- AND C-REL ONCOPROTEINS$231,486
R01 · FY2000 · CA